Announcements Trials

Browse Landscape

Phase

Status

Completed 13 Unknown 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cisplatin 122 Carboplatin 121 Drug Therapy 118 Bevacizumab 105 Capecitabine 99 Oxaliplatin 97 Radiotherapy 95 Paclitaxel 88 Gemcitabine 88 tislelizumab 87 Cyclophosphamide 86 Specimen Handling 80 pembrolizumab 76 toripalimab 67 Magnetic Resonance Spectroscopy 65 Fluorouracil 62 sintilimab 59 Injections 57 Surgical Procedures, Operative 56 Docetaxel 54 anlotinib 51 130-nm albumin-bound paclitaxel 48 Immune Checkpoint Inhibitors 47 fludarabine 46 Standard of Care 45 Pemetrexed 43 Blood Specimen Collection 43 Biopsy 43 venetoclax 41 lenvatinib 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Peptides × Clear all

NCT06195618 2025-06-25

TEBICA003 TNBC

Universidad Nacional de Colombia

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡